Jayaraj Rajagopal, MD, MGH Research Scholar Profile
MGH Research Scholars Program
The MGH Research Scholars Program was established to support early career researchers with innovative yet unproven ideas that have the potential to transform the future of medicine. Funded 100% through philanthropy, this program gives researchers the freedom and flexibility they need to follow the science wherever it leads. History has shown that brilliant scientists who are given free rein to explore new frontiers make the greatest, often unexpected, advances.
The laboratory of MGH Research Scholar Jay Rajagopal, MD, is using cell culturing techniques to study respiratory disorders such as Cystic Fibrosis.
Dissecting the Basis of Airway Epithelial Regeneration and Human Lung Disease Using Stem Cell Biology
I am a basic and translational cancer researcher and practicing medical oncologist at the Massachusetts General Hospital Cancer Center, and an Associate Professor of Medicine at Harvard Medical School. I also direct the breast and ovarian cancer genetics program at Mass General.
The majority of my time is spent on basic research, the goal of which is to understand transcription factor deregulation as a means to therapeutically target and identify biomarkers of treatment response in a broad spectrum of human cancers.
As co-Executive Director of the Translational Research Laboratory (TRL) for tumor molecular profiling at the Mass General Cancer Center, our translational research focuses developing and implementing technologies for tumor molecular analysis to advance the goal of individualized cancer treatment.
44 Mass General Investigators Named Highly Cited Researchers of 2022
According to Clarivate Analytics’ Highly Cited Researchers Report
Research at Mass General
Every day, our clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and advance patient care.